These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8939968

  • 1. Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain.
    Cao J, Rehemtulla A, Bahou W, Zucker S.
    J Biol Chem; 1996 Nov 22; 271(47):30174-80. PubMed ID: 8939968
    [Abstract] [Full Text] [Related]

  • 2. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator.
    Okumura Y, Sato H, Seiki M, Kido H.
    FEBS Lett; 1997 Feb 03; 402(2-3):181-4. PubMed ID: 9037191
    [Abstract] [Full Text] [Related]

  • 3. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H, Atkinson SJ, Butler GS, Smith B, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17119-23. PubMed ID: 8663332
    [Abstract] [Full Text] [Related]

  • 4. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
    Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y.
    Cancer Res; 1996 Jun 15; 56(12):2707-10. PubMed ID: 8665498
    [Abstract] [Full Text] [Related]

  • 5. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
    Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, Seiki M.
    FEBS Lett; 1996 May 06; 385(3):238-40. PubMed ID: 8647259
    [Abstract] [Full Text] [Related]

  • 6. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H.
    Biol Chem; 1997 Feb 06; 378(2):71-6. PubMed ID: 9088534
    [Abstract] [Full Text] [Related]

  • 7. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
    Cao J, Rehemtulla A, Pavlaki M, Kozarekar P, Chiarelli C.
    J Biol Chem; 2005 Mar 25; 280(12):10974-80. PubMed ID: 15637056
    [Abstract] [Full Text] [Related]

  • 8. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
    Santavicca M, Noel A, Angliker H, Stoll I, Segain JP, Anglard P, Chretien M, Seidah N, Basset P.
    Biochem J; 1996 May 01; 315 ( Pt 3)(Pt 3):953-8. PubMed ID: 8645182
    [Abstract] [Full Text] [Related]

  • 9. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A, Tomasetto C, Lutz Y, Bellocq JP, Rio MC, Basset P.
    J Cell Biol; 1997 Apr 07; 137(1):67-77. PubMed ID: 9105037
    [Abstract] [Full Text] [Related]

  • 10. Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
    Pei D, Weiss SJ.
    Nature; 1995 May 18; 375(6528):244-7. PubMed ID: 7746327
    [Abstract] [Full Text] [Related]

  • 11. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J, Drews M, Lee HM, Conner C, Bahou WF, Zucker S.
    J Biol Chem; 1998 Dec 25; 273(52):34745-52. PubMed ID: 9856998
    [Abstract] [Full Text] [Related]

  • 12. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.
    Lehti K, Lohi J, Valtanen H, Keski-Oja J.
    Biochem J; 1998 Sep 01; 334 ( Pt 2)(Pt 2):345-53. PubMed ID: 9716492
    [Abstract] [Full Text] [Related]

  • 13. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation.
    Cao J, Sato H, Takino T, Seiki M.
    J Biol Chem; 1995 Jan 13; 270(2):801-5. PubMed ID: 7822314
    [Abstract] [Full Text] [Related]

  • 14. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
    Xia T, Akers K, Eisen AZ, Seltzer JL.
    Biochim Biophys Acta; 1996 Apr 16; 1293(2):259-66. PubMed ID: 8620038
    [Abstract] [Full Text] [Related]

  • 15. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
    Pei D, Weiss SJ.
    J Biol Chem; 1996 Apr 12; 271(15):9135-40. PubMed ID: 8621565
    [Abstract] [Full Text] [Related]

  • 16. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts.
    Li L, Akers K, Eisen AZ, Seltzer JL.
    Exp Cell Res; 1997 May 01; 232(2):322-30. PubMed ID: 9168808
    [Abstract] [Full Text] [Related]

  • 17. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, López-Otín C.
    Cancer Res; 2000 Feb 15; 60(4):877-82. PubMed ID: 10706098
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms for pro matrix metalloproteinase activation.
    Murphy G, Stanton H, Cowell S, Butler G, Knäuper V, Atkinson S, Gavrilovic J.
    APMIS; 1999 Jan 15; 107(1):38-44. PubMed ID: 10190278
    [Abstract] [Full Text] [Related]

  • 19. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T, Sato H, Takino T, Itoh M, Akizawa T, Seiki M.
    Cancer Res; 1996 Jun 01; 56(11):2535-8. PubMed ID: 8653693
    [Abstract] [Full Text] [Related]

  • 20. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.
    Leduc R, Molloy SS, Thorne BA, Thomas G.
    J Biol Chem; 1992 Jul 15; 267(20):14304-8. PubMed ID: 1629222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.